TORONTO, Ontario, June 23, 2021 – Awakn Life Sciences Corp. (“Awakn” or the “Company”) a biotechnology company with clinical operations developing, and delivering psychedelic medicines to treat Addiction, is pleased to announce it will begin trading today, June 23, 2021, on the NEO Exchange Inc. (the “NEO”) under the symbol “AWKN”. “Listing on the NEO is an important milestone for Awakn to…


Previous articleCOMPASS Pathways becomes Founding Supporter of the British Neuroscience Association’s inaugural Scholars programme
Next articleBook Review: Alexander Shulgin’s The Nature of Drugs